Abdurrahman A, Rijal MAS, Yusuf H, Norhayati, Rizaldi G. In silico study of naringin as an anti-HER-2 receptor in the treatment of breast cancer. Borneo J of Pharmascientech [Internet]. 2024Oct.21 [cited 2025Jul.30];8(2):137-48. Available from: https://jurnalstikesborneolestari.ac.id/index.php/borneo/article/view/535